Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.1%

420 terminated/withdrawn out of 3217 trials

Success Rate

80.9%

-5.6% vs industry average

Late-Stage Pipeline

11%

350 trials in Phase 3/4

Results Transparency

55%

979 of 1784 completed trials have results

Key Signals

411 recruiting979 with results249 terminated171 withdrawn

Enrollment Performance

Analytics

N/A

1468(55.1%)

Phase 2

509(19.1%)

Phase 1

279(10.5%)

Phase 4

245(9.2%)

Phase 3

105(3.9%)

Early Phase 1

60(2.3%)

2666Total

N/A(1468)

Phase 2(509)

Phase 1(279)

Phase 4(245)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3217)

Showing 20 of 3217 trials

NCT04860336Completed

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Role: collaborator

NCT04297683Phase 2Recruiting

HEALEY ALS Platform Trial - Master Protocol

Role: collaborator

NCT06375265Not ApplicableRecruiting

Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients

Role: lead

NCT05013892Phase 2Recruiting

NTS-WBRT in Brain Metastases

Role: lead

NCT06967545Not ApplicableRecruiting

A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior

Role: lead

NCT05642715Not ApplicableRecruiting

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

Role: collaborator

NCT05881304Not ApplicableCompleted

Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC

Role: lead

NCT02816697Not ApplicableCompleted

Implementation of a System-level Tobacco Treatment Intervention

Role: collaborator

NCT03922555Phase 1Recruiting

ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas

Role: lead

NCT05010590Phase 4Active Not Recruiting

Anabolic Therapy in Postmenopausal Osteoporosis

Role: lead

NCT07018726Not ApplicableRecruiting

Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners

Role: lead

NCT06716931Not ApplicableRecruiting

Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)

Role: lead

NCT06373016Not ApplicableRecruiting

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

Role: collaborator

NCT04271774Completed

Genome Environment Microbiome and Metabolome in Autism Study

Role: lead

NCT02693990Not ApplicableActive Not Recruiting

A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

Role: lead

NCT06721819Phase 3Recruiting

The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium

Role: collaborator

NCT05393622Not ApplicableRecruiting

Brain Stimulation for Severe Depression

Role: collaborator

NCT01512589Phase 2Active Not Recruiting

Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial

Role: collaborator

NCT03286335Not ApplicableRecruiting

Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy

Role: lead

NCT06265532Phase 1Completed

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Role: collaborator